The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Cardiovascular Disease Among Survivors of Adult-Onset Cancer: A Community-Based Retrospective Cohort Study
Open accessAbstract
Purpose: Cardiovascular diseases (CVDs), including ischemic heart disease, stroke, and heart failure, are well-established late effects of therapy in survivors of childhood and young adult (< 40 years at diagnosis) cancers; less is known regarding CVD in long-term survivors of adult-onset (≥ 40 years) cancer. Methods: A retrospective cohort study design was used to describe the magnitude of CVD risk in 36,232 ≥ 2-year survivors of adult-onset cancer compared with matched (age, sex, and residential ZIP code) noncancer controls (n = 73,545) within a large integrated managed care organization. Multivariable regression was used to examine the impact of cardiovascular risk factors (CVRFs; hypertension, diabetes, dyslipidemia) on long-term CVD risk in cancer survivors. Results: Survivors of multiple myeloma (incidence rate ratio [IRR], 1.70; P < .01), carcinoma of the lung/bronchus (IRR, 1.58; P < .01), non-Hodgkin lymphoma (IRR, 1.41; P < .01), and breast cancer (IRR, 1.13; P < .01) had significantly higher CVD risk when compared with noncancer controls. Conversely, prostate cancer survivors had a lower CVD risk (IRR, 0.89; P < .01) compared with controls. Cancer survivors with two or more CVRFs had the highest risk of CVD when compared with noncancer controls with less than two CVRFs (IRR, 1.83 to 2.59; P < .01). Eight-year overall survival was significantly worse among cancer survivors who developed CVD (60%) when compared with cancer survivors without CVD (81%; P < .01). Conclusion: The magnitude of subsequent CVD risk varies according to cancer subtype and by the presence of CVRFs. Overall survival in survivors who develop CVD is poor, emphasizing the need for targeted prevention strategies for individuals at highest risk of developing CVD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer treatment and survivorship statistics, 2016
Miller, K. D., Siegel, R. L., Lin, C. C., Mariotto, A. B., Kramer, J. L., Rowland, J. H., Stein, K. D., Alteri, R., & Jemal, A. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21349 · Cited by 6,066
A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk
Gray, R. J. (1988) · The Annals of Statistics · doi:10.1214/aos/1176350951 · Cited by 4,960
Cancer treatment and survivorship statistics, 2014
DeSantis, C. E., Lin, C. C., Mariotto, A. B., Siegel, R. L., Stein, K. D., Kramer, J. L., Alteri, R., Robbins, A. S., & Jemal, A. (2014) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21235 · Cited by 2,779
Projections of the cost of cancer care in the United States: 2010–2020
Mariotto, A. B., Robin Yabroff, K., Shao, Y., Feuer, E. J., & Brown, M. L. (2011) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djq495 · Cited by 2,657
Swain, S. M., Whaley, F. S., & Ewer, M. S. (2003) · Cancer · doi:10.1002/cncr.11407 · Cited by 2,313
Cardiac Dysfunction in the Trastuzumab Clinical Trials Experience
Seidman, A. D., Hudis, C. A., Pierri, M. K., Shak, S., Paton, V. E., Ashby, M. A., Murphy, M., Stewart, S. J., & Keefe, D. L. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.5.1215 · Cited by 1,563
Cardiovascular Complications of Cancer Therapy: Diagnosis, Pathogenesis, and Management
Yeh, E. T. H., Tong, A. T., Lenihan, D. J., Yusuf, S. W., Swafford, J., Champion, C., Durand, J.-B., Gibbs, H., Zafarmand, A. A., & Ewer, M. S. (2004) · Circulation · doi:10.1161/01.cir.0000133187.74800.b9 · Cited by 843
Koebnick, C., Langer-Gould, A. M., Gould, M. K., Chao, C. R., Iyer, R. L., Smith, N., Chen, W., & Jacobsen, S. J. (2012) · The Permanente Journal · doi:10.7812/tpp/12-031 · Cited by 789
Self-citationModifiable Risk Factors and Major Cardiac Events Among Adult Survivors of Childhood Cancer
Armstrong, G. T., Oeffinger, K. C., Chen, Y., Kawashima, T., Yasui, Y., Leisenring, W., Stovall, M., Chow, E. J., Sklar, C. A., Mulrooney, D. A., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.49.3205 · Cited by 734
de Moor, J. S., Mariotto, A. B., Parry, C., Alfano, C. M., Padgett, L., Kent, E. E., Forsythe, L., Scoppa, S., Hachey, M., & Rowland, J. H. (2013) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-12-1356 · Cited by 670
Hull, M. C. (2003) · JAMA · doi:10.1001/jama.290.21.2831 · Cited by 644
Lipshultz, S. E., Adams, M. J., Colan, S. D., Constine, L. S., Herman, E. H., Hsu, D. T., Hudson, M. M., Kremer, L. C., Landy, D. C., Miller, T. L., et al. (2013) · Circulation · doi:10.1161/cir.0b013e3182a88099 · Cited by 612
Jiles, R. B., Hughes, E., Murphy, W., Flowers, N., McCracken, M., Roberts, H., Ochner, M., Balluz, L. S., Mokdad, A., Elam–Evans, L. D., et al. (2005) · PubMed · Cited by 595
Bowles, E. J. A., Wellman, R., Feigelson, H. S., Onitilo, A. A., Freedman, A. N., Delate, T., Allen, L. A., Nekhlyudov, L., Goddard, K. A. B., Davis, R. L., et al. (2012) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djs317 · Cited by 566
Perez, E. A., Suman, V. J., Davidson, N. E., Sledge, G. W., Kaufman, P. A., Hudis, C. A., Martino, S., Gralow, J. R., Dakhil, S. R., Ingle, J. N., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.5467 · Cited by 538
Hershman, D. L., McBride, R. B., Eisenberger, A., Tsai, W. Y., Grann, V. R., & Jacobson, J. S. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.1242 · Cited by 390
Guarneri, V., Lenihan, D. J., Valero, V., Durand, J.-B., Broglio, K., Hess, K. R., Michaud, L. B., Gonzalez-Angulo, A. M., Hortobagyi, G. N., & Esteva, F. J. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.9551 · Cited by 361
Subclinical Late Cardiomyopathy After Doxorubicin Therapy for Lymphoma in Adults
Hequet, O., Le, Q. H., Moullet, I., Pauli, E., Salles, G., Espinouse, D., Dumontet, C., Thieblemont, C., Arnaud, P., Antal, D., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.06.033 · Cited by 340
Chemotherapy and Cardiotoxicity in Older Breast Cancer Patients: A Population-Based Study
Doyle, J. J., Neugut, A. I., Jacobson, J. S., Grann, V. R., & Hershman, D. L. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.5841 · Cited by 335
O'Farrell, S., Garmo, H., Holmberg, L., Adolfsson, J., Stattin, P., & Van Hemelrijck, M. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.59.1792 · Cited by 265
Trastuzumab-Related Cardiotoxicity Among Older Patients With Breast Cancer
Chavez-MacGregor, M., Zhang, N., Buchholz, T. A., Zhang, Y., Niu, J., Elting, L., Smith, B. D., Hortobagyi, G. N., & Giordano, S. H. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.48.7884 · Cited by 244
Elliott, M. N., Fremont, A., Morrison, P. A., Pantoja, P., & Lurie, N. (2008) · Health Services Research · doi:10.1111/j.1475-6773.2008.00854.x · Cited by 206
Late Cardiac Effects of Cancer Treatment
Lenihan, D. J., & Cardinale, D. M. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.45.2938 · Cited by 178
Xu, F., Town, M., Balluz, L. S., Bartoli, W. P., Murphy, W., Chowdhury, P. P., Garvin, W. S., Pierannunzi, C. A., Zhong, Y., Salandy, S. W., et al. (2007) · PubMed · Cited by 138
Early cardiotoxicity of the CHOP regimen in aggressivenon-Hodgkin’s lymphoma
Limat, S., Demesmay, K., Voillat, L., Bernard, Y. F., Deconinck, É., Brion, A., Rebibo-Sabbah, A., Woronoff-Lemsi, M. C., & Cahn, J.-Y. Y. (2003) · Annals of Oncology · doi:10.1093/annonc/mdg070 · Cited by 133
Rugbjerg, K., Mellemkjær, L., Boice, J. D., Køber, L., Ewertz, M., & Olsen, J. H. (2014) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dju110 · Cited by 124
Derose, S. F., Contreras, R., Coleman, K. J., Koebnick, C., & Jacobsen, S. J. (2013) · Medical Care Research and Review · doi:10.1177/1077558712466293 · Cited by 102
Cardiovascular disease in survivors of hematopoietic cell transplantation
Armenian, S. H., & Chow, E. J. (2013) · Cancer · doi:10.1002/cncr.28444 · Cited by 89
Self-citationCardiac Effects of Anticancer Therapy in the Elderly
Accordino, M. K., Neugut, A. I., & Hershman, D. L. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.55.0459 · Cited by 85
Ganz, P. A., Hussey, M. A., Moinpour, C. M., Unger, J. M., Hutchins, L. F., Dakhil, S. R., Giguere, J. K., Goodwin, J. W., Martino, S., & Albain, K. S. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.8877 · Cited by 85
Cardiovascular events, early discontinuation of trastuzumab, and their impact on survival
Wang, S., Long, J. B., Hurria, A., Owusu, C., Steingart, R. M., Gross, C. P., & Chen, J. (2014) · Breast Cancer Research and Treatment · doi:10.1007/s10549-014-3029-0 · Cited by 79
Cardiovascular Disease Risk Assessment and Prevention
Alagona, P., & Ahmad, T. A. (2015) · Medical Clinics of North America · doi:10.1016/j.mcna.2015.02.003 · Cited by 57
Chen, L., Quinn, V. P., Xu, L., Gould, M. K., Jacobsen, S. J., Koebnick, C., Reynolds, K., Hechter, R. C., & Chao, C. (2013) · Substance Use & Misuse · doi:10.3109/10826084.2013.787095 · Cited by 37
Self-citationCardiovascular Disease Associated With Androgen-Deprivation Therapy: Time to Give It Due Respect
Basaria, S. S. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.60.2649 · Cited by 14
Trastuzumab-Related Cardiotoxicity Among Older Patients With Breast Cancer
Freedman, R. A. (2015) · Breast Diseases A Year Book Quarterly · doi:10.1016/j.breastdis.2015.04.035 · Cited by 10
Cited by
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
Visseren, F. L. J., Mach, F., Smulders, Y. M., Carballo, D., Koskinas, K. C., Bäck, M., Benetos, A., Biffi, A., Boavida, J.-M., Capodanno, D., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab484 · Cited by 6,485
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
Gradishar, W. J., Anderson, B. O., Balassanian, R., Blair, S. L., Burstein, H. J., Cyr, A., Elias, A. D., Farrar, W. B., Forero, A., Giordano, S. H., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0012 · Cited by 1,609
Armenian, S. H., Lacchetti, C., Barac, A., Carver, J., Constine, L. S., Denduluri, N., Dent, S., Douglas, P. S., Durand, J.-B., Ewer, M., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.70.5400 · Cited by 1,290
Self-citationCurigliano, G., Lenihan, D., Fradley, M., Ganatra, S., Barac, A., Blaes, A., Herrmann, J., Porter, C., Lyon, A. R., Lancellotti, P., et al. (2020) · Annals of Oncology · doi:10.1016/j.annonc.2019.10.023 · Cited by 1,031
Self-citationA population-based study of cardiovascular disease mortality risk in US cancer patients
Sturgeon, K. M., Deng, L., Bluethmann, S. M., Zhou, S., Trifiletti, D. M., Jiang, C., Kelly, S. P., & Zaorsky, N. G. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz766 · Cited by 923
Metadata
- Authors
- Armenian, S. H., Xu, L., Ky, B., Sun, C., Farol, L. T., Pal, S. K., Douglas, P. S., Bhatia, S., & Chao, C.
- Venue
- Journal of Clinical Oncology
- Published
- 2016-04-01
- Volume
- 34
- Issue
- 10
- Pages
- 1122-1130
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2260466831
- Cited by
- 559
- References
- 36
- FWCI
- 25.90
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.